This site is intended for healthcare professionals
Magnifying glass on blue background; searching for results

Find disease awareness content and relevant supporting materials

Learning Zone 472 Events 10 News 19961 Drugs 42497 Trials 863 Guidelines 631 Journals 1966
Filter results
Sort by:
Relevance
to
Blue test tubes arranged in a line, disappearing into the background
News
26/03/25

New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings - AstraZeneca

  • 7 min read
Blue test tubes arranged in a line, disappearing into the background
News
25/03/25

The FDA has issued a second complete response letter for camrelizumab + rivoceranib as a treatment for unresectable or metastatic hepatocellular carcinoma- Jiangsu Hengrui + Elevar Therapeutics

  • 1 min read
Latest industry news
News
22/03/25

Parateck to acquire Optinose and with it Xhance (fluticasone propionate).

  • 1 min read
Latest industry news
News
20/03/25

Alvotech acquires the research operations of Xbrane Biopharma AB and with it XB 003 referencing Cimzia (certolizumab pegol).

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
20/03/25

New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference - UCB

  • 2 min read
Blue test tubes arranged in a line, disappearing into the background
News
19/03/25

Nipocalimab has now received Fast Track Designation for Sjögren’s disease - Johnson & Johnson

  • 2 min read
Blue test tubes arranged in a line, disappearing into the background
News
19/03/25

FDA accepts a 351(k) BLA submission for AVT 03 a proposed biosimilar of Prolia (denosumab) and Xgeva (denosumab).- Alvotech + Dr Reddy's

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
18/03/25

New data from phase II trial with stenoparib monotherapy in advanced ovarian cancer .- Alarity Therapeutics

  • 3 min read
Blue test tubes arranged in a line, disappearing into the background
News
28/03/25

Application to expand use of Nucala (mepolizumab) for the treatment of COPD accepted for review by the European Medicines Agency - GSK

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
News
30/03/25

FDA approves denosumab biosimilars Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht.- Fresenius Kabi

  • 1 min read
See more